To Assess the Correlation of Serum Phosphorus Level in Diabetic Ketoacidosis in Type-2 Diabetes Mellitus
Authors/Creators
- 1. Resident Doctor, MD General Medicine, Jawahar Lal Nehru Medical College, Ajmer (Raj.)
- 2. Senior Professor, Department of General Medicine, Jawahar Lal Nehru Medical, College, Ajmer (Raj.)
- 3. Assistant Professor, Department of General Medicine, Jawahar Lal Nehru Medical College, Ajmer (Raj.)
Description
Background: In DKA patients, phosphate and magnesium level are decreased and further reduction may occur during insulin treatment. But, usually, these electrolytes are not given, when the patient takes oral diet. If the phosphate level is low, and the patient is not taking oral diet, potassium phosphate can be given. If magnesium level found low level in DKA patient, who developed cardiac arrhythmias, magnesium sulfate can be given. Otherwise, routine supplementation is not needed. Methods: Phosphorus levels was estimated on 1 day, 3 day and discharge/worsening of patient. It was correlated to prognosis of patient in diabetic ketoacidosis in type-2 diabetes mellitus. Result-Phosphorous levels at Day 1, 3 and during discharge or condition worsening in patients with Type 2 diabetes mellitus with ketoacidosis (Study group) Phosphorous levels at Day 1, 3 and during discharge or condition worsening in patients with Type 2 diabetes mellitus without ketoacidosis (Control group) Conclusion: We conclude that phosphorus the neglected aspect of diabetic ketoacidosis needs due consideration. Significant negative correlation was observed between RBS levels and serum phosphorus levels. Significant long length of hospitalization was observed in diabetic ketoacidosis patients having low phosphorus levels.
Abstract (English)
Background: In DKA patients, phosphate and magnesium level are decreased and further reduction may occur during insulin treatment. But, usually, these electrolytes are not given, when the patient takes oral diet. If the phosphate level is low, and the patient is not taking oral diet, potassium phosphate can be given. If magnesium level found low level in DKA patient, who developed cardiac arrhythmias, magnesium sulfate can be given. Otherwise, routine supplementation is not needed. Methods: Phosphorus levels was estimated on 1 day, 3 day and discharge/worsening of patient. It was correlated to prognosis of patient in diabetic ketoacidosis in type-2 diabetes mellitus. Result-Phosphorous levels at Day 1, 3 and during discharge or condition worsening in patients with Type 2 diabetes mellitus with ketoacidosis (Study group) Phosphorous levels at Day 1, 3 and during discharge or condition worsening in patients with Type 2 diabetes mellitus without ketoacidosis (Control group) Conclusion: We conclude that phosphorus the neglected aspect of diabetic ketoacidosis needs due consideration. Significant negative correlation was observed between RBS levels and serum phosphorus levels. Significant long length of hospitalization was observed in diabetic ketoacidosis patients having low phosphorus levels.
Files
IJPCR,Vol15,Issue11,Article177.pdf
Files
(294.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:75690f80fda9d3da8c2f66c63f6cd9e3
|
294.0 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-10-30
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue11,Article177.pdf
- Development Status
- Active
References
- 1. Krebs, E.G. and Beavo, J.A. (1979) Phosphorylation-Dephosphorylation of Enzymes. Annual Review of Biochemistry, Annual Reviews. 48, 923–59. https://doi.org/ 10.1146/annurev.bi.48.070179.004423 2. Nelson, S.M.L., Sarabia, S.R.S., Christilaw, E., Ward, E.C., Lynch, S.K., Adams, M.A. et al. (2017) Phosphate-Containing Prescription Medications Contribute to the Daily Phosphate Intake in a Third of Hemodialysis Patients. Journal of Renal Nutrition, Elsevier BV. 27, 91–6. https://doi.org/10.1053/j.jrn.2016.09.007 3. Kitabchi, A.E. and Nyenwe, E.A. (2006) Hyperglycemic Crises in Diabetes Mellitus: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State. Endocrinol. Metab. Clin. North Am. https://doi.org/10.1016/j.ecl.20 06.09.006 4. Becker, D.J., Brown, D.R., Steranka, B.H. and Drash, A.L. (1983) Phosphate replacement during treatment of diabetic ketosis. Effects on calcium and phosphorus homeostasis. American Journal of Diseases of Children (1960), United States. 137, 241–6. https://doi .org/10.1001/archpedi.1983.02140290033009 5. Huang, D., Refaat, M., Mohammedi, K., Jayyousi, A., Al Suwaidi, J. and Abi Khalil, C. (2017) Macrovascular Complications in Patients with Diabetes and Prediabetes. Biomed Res. Int. https://doi.org/10.1155/2 017/7839101 6. Tahrani, A.A., Piya, M.K., Kennedy, A. and Barnett, A.H. (2010) Glycaemic control in type 2 diabetes: Targets and new therapies. Pharmacology & Therapeutics, 125, 328–61. https://doi.org/https://doi.org/10.1016/j.pharmt hera.2009.11.001 7. Desfougères, Y., Saiardi, A. and Azevedo, C. (2020) Inorganic polyphosphate in mammals: where's Wally? Biochemical Society Transactions, Portland Press Ltd. 48, 95–101. https://doi.org/10.1042/BST20190328 8. Miller, D. and Slovis, C. (2000) Hypophosphatemia in the emergency department therapeutics. The American Journal of Emergency Medicine, 18, 457–61. https://doi.org/10.1053/ajem.2000.7347